These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 25657248)

  • 1. Addiction therapy. Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology.
    Creed M; Pascoli VJ; Lüscher C
    Science; 2015 Feb; 347(6222):659-64. PubMed ID: 25657248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroscience: spotlight on deep-brain stimulation.
    Benabid AL
    Nature; 2015 Mar; 519(7543):299-300. PubMed ID: 25788094
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward a targeted treatment for addiction.
    Creed MC
    Science; 2017 Aug; 357(6350):464-465. PubMed ID: 28774920
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour.
    Pascoli V; Turiault M; Lüscher C
    Nature; 2011 Dec; 481(7379):71-5. PubMed ID: 22158102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optogenetically inspired deep brain stimulation: linking basic with clinical research.
    Lüscher C; Pollak P
    Swiss Med Wkly; 2016; 146():w14278. PubMed ID: 27045196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic dissection of neural circuitry: from synaptic causalities to blue prints for novel treatments of behavioral diseases.
    Lüscher C; Pascoli V; Creed M
    Curr Opin Neurobiol; 2015 Dec; 35():95-100. PubMed ID: 26264408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optogenetic reversal of cocaine-evoked synaptic potentiation normalizes behavioural sensitization].
    Lüscher C; Pascoli V
    Med Sci (Paris); 2012 Apr; 28(4):353-5. PubMed ID: 22549856
    [No Abstract]   [Full Text] [Related]  

  • 8. Transition to addiction is associated with a persistent impairment in synaptic plasticity.
    Kasanetz F; Deroche-Gamonet V; Berson N; Balado E; Lafourcade M; Manzoni O; Piazza PV
    Science; 2010 Jun; 328(5986):1709-12. PubMed ID: 20576893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area.
    Bocklisch C; Pascoli V; Wong JC; House DR; Yvon C; de Roo M; Tan KR; Lüscher C
    Science; 2013 Sep; 341(6153):1521-5. PubMed ID: 24072923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emergence of a Circuit Model for Addiction.
    Lüscher C
    Annu Rev Neurosci; 2016 Jul; 39():257-76. PubMed ID: 27145911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate receptors on dopamine neurons control the persistence of cocaine seeking.
    Engblom D; Bilbao A; Sanchis-Segura C; Dahan L; Perreau-Lenz S; Balland B; Parkitna JR; Luján R; Halbout B; Mameli M; Parlato R; Sprengel R; Lüscher C; Schütz G; Spanagel R
    Neuron; 2008 Aug; 59(3):497-508. PubMed ID: 18701074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture.
    Burguière A; De Bundel D; Valjent E; Roger J; Smolders I; Fagni L; Perroy J
    Neuropharmacology; 2013 Mar; 66():151-7. PubMed ID: 22465815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mimicking synaptic effects of addictive drugs with selective dopamine neuron stimulation.
    Brown MT; Korn C; Lüscher C
    Channels (Austin); 2011; 5(6):461-3. PubMed ID: 21785269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasticity-dependent changes in metabotropic glutamate receptor expression at excitatory hippocampal synapses.
    Cheyne JE; Montgomery JM
    Mol Cell Neurosci; 2008 Mar; 37(3):432-9. PubMed ID: 18191411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between glutamate transporters and metabotropic glutamate receptors at excitatory synapses in the cerebellar cortex.
    Otis TS; Brasnjo G; Dzubay JA; Pratap M
    Neurochem Int; 2004 Sep; 45(4):537-44. PubMed ID: 15186920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Shining light on translational research in deep brain stimulation].
    Lüscher C; Davoine E; Bellone C
    Rev Med Suisse; 2015 Apr; 11(472):987-8, 990-1. PubMed ID: 26062226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum.
    Narushima M; Hashimoto K; Kano M
    Neurosci Res; 2006 Mar; 54(3):159-64. PubMed ID: 16413076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors.
    Huang YY; Simpson E; Kellendonk C; Kandel ER
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3236-41. PubMed ID: 14981263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic plasticity and addiction: learning mechanisms gone awry.
    Mameli M; Lüscher C
    Neuropharmacology; 2011 Dec; 61(7):1052-9. PubMed ID: 21277315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Involvement and plasticity of brainstem cholinergic neurons in cocaine-induced addiction].
    Kaneda K; Shinohara F; Kurosawa R; Taoka N; Ide S; Minami M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Apr; 49(2):92-103. PubMed ID: 24946392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.